L-ELISA for the human lymphocyte activation gene 3 (human LAG-3) (CD223) quantifies human LAG-3 in serum, plasma, buffered solution or human cell culture medium. The test will recognize exclusively the LAG-3 Hu...
L-ELISA for the human lymphocyte activation gene 3 (human LAG-3) (CD223) quantifies human LAG-3 in serum, plasma, buffered solution or human cell culture medium. The test will only recognize natural and recombinant LAG-3 Hu. Method Principle The human LAG-3 solid phase ELISA sandwich test (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
CD-223 protein (LAG-3, lymphocyte activation protein 3) is a 70 kDa surface glycoprotein in the Ig superfamily. CD-223 binds to Class II MHC with higher affinity than CD4. It is also considered to be involved in the negative regulation of T cell activation and homeostatic proliferation. The surface expression of CD-223 was reported on activated T cells (including regulatory T cells) and NK lymphocytes. CD8+ T cells generally express CD-223 at significantly higher levels than CD4+ T cells. Coexpression of CD-223 and CD49b has been proposed to identify T-cells that regulate type 1 (Tr1 cells) in humans and mice. The LAG-3 protein contains 4 extracellular domains similar to Ig; its gene contains 8 exons. Sequence data, exon/intron organization and chromosome localization all indicate the homology of CD-223 to CD4.
Sensitivity
Sensitivity of the dosage: 2.20 pg/ml.
Measurement range
Dose range: 6.2-400 pg/ml.
Duration of dosing
Total duration of dosing: 3 h 30 min.
Reproducibility
Coefficient of intra-dose variation 5.8%, inter-dose 6.9%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15991087 |
| Specifications |
| Accession number | P18627 |
| Dose range | 6.2-400 pg/ml |
| Sensitivity of the dosage | 2.20 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant, Supernatant |
| Target species | Human |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 3902 |
| Gene symbol(s) | CD223 |
| Coefficient of inter-dose variation | 6.9% |
| Coefficient of intra-dose variation | 5.8% |
| Contents of kits | Pre-coated well plate 96, Standard, sample diluent, dosing buffer concentrate, biotinylated detection antibodies, SAV-HRP, washing pad, chromogen, stop solution, adhesive film for plates |
| Marker or dye | HRP |
| Quantity | 96 Tests |
| Regulatory status | RUO |
| Target | Human |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 10 μl; serum, 10 μl; supernatant, 10 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 3 h 30 min |
Origin and customs
| Manufacturer ref. | BMS2211 |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.